These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15084917)

  • 1. An analog peptide that suppresses collagen-induced arthritis.
    Myers LK; Sakurai Y; Rosloniec EF; Stuart JM; Kang AH
    Am J Med Sci; 2004 Apr; 327(4):212-6. PubMed ID: 15084917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
    Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
    Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
    Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
    Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
    Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.
    Myers LK; Tang B; Brand DD; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2004 Sep; 50(9):3004-11. PubMed ID: 15457470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis.
    Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
    J Immunol; 2013 Jun; 190(11):5382-91. PubMed ID: 23630354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints.
    Latham KA; Whittington KB; Zhou R; Qian Z; Rosloniec EF
    J Immunol; 2005 Apr; 174(7):3978-85. PubMed ID: 15778354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.
    Kimata M; Cullins DL; Brown ML; Brand DD; Rosloniec EF; Myers LK; Stuart JM; Kang AH
    Arthritis Res Ther; 2012 May; 14(3):R107. PubMed ID: 22569209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.
    Rosloniec EF; Brand DD; Myers LK; Whittington KB; Gumanovskaya M; Zaller DM; Woods A; Altmann DM; Stuart JM; Kang AH
    J Exp Med; 1997 Mar; 185(6):1113-22. PubMed ID: 9091584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
    He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
    Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
    von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
    Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic mice.
    von Delwig A; Hilkens CM; Altmann DM; Holmdahl R; Isaacs JD; Harding CV; Robertson H; McKie N; Robinson JH
    Arthritis Res Ther; 2006; 8(4):R93. PubMed ID: 16704744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell immunity to type II collagen in the biobreeding rat: the identification and characterization of RT1u-restricted T cell epitopes on alpha 1(II).
    Cremer MA; Ye XJ; Myers LK; Brand DD; Rosloniec EF; Kang AH
    J Immunol; 2004 Aug; 173(3):1795-801. PubMed ID: 15265910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis.
    Myers LK; Rosloniec EF; Seyer JM; Stuart JM; Kang AH
    J Immunol; 1993 May; 150(10):4652-8. PubMed ID: 8482852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8
    Whittington KB; Prislovsky A; Beaty J; Albritton L; Radic M; Rosloniec EF
    J Immunol; 2022 Jan; 208(1):16-26. PubMed ID: 34819392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An altered peptide ligand of type II collagen suppresses autoimmune arthritis.
    Myers LK; Tang B; Rosioniec EF; Stuart JM; Kang AH
    Crit Rev Immunol; 2007; 27(4):345-56. PubMed ID: 18197813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis.
    Tang B; Kim S; Hammond S; Cullins DL; Brand DD; Rosloniec EF; Stuart JM; Postlethwaite AE; Kang AH; Myers LK
    Arthritis Res Ther; 2014 Jan; 16(1):R7. PubMed ID: 24405551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.